Showing results (2211-2220 of 3,120) with videos related to

Sort By:
Pageof 312
The Pediatric Infectious Disease Journal|February 1, 1987
Aerosolized ribavirin in the treatment of patients with respiratory syncytial virus diseaseW J Rodriguez, H W Kim, C D Brandt, et al.
Therapeutic Advances in Infectious Disease|September 4, 2023
Hospitalization risk among patients with Mpox infection-a propensity score matched analysisAndrés F Henao-Martínez, Chloe M Orkin, Boghuma K Titanji, et al.
Current Tropical Medicine Reports|November 8, 2021
A Review of the Scientific Contributions of Nepal on COVID-19Rupesh Raut, Ranjit Sah, Kritika Dixit, et al.
The Oncologist|September 15, 2022
Open-Label Placebo for the Treatment of Cancer-Related Fatigue in Patients with Advanced Cancer: A Randomized Controlled TrialSriram Yennurajalingam, Ahsan Azhar, Zhanni Lu, et al.
Annals of Clinical and Translational Neurology|February 17, 2021
Deep brain stimulation effects on verbal fluency dissociated by target and active contact locationKevin D John, Scott A Wylie, Benoit M Dawant, et al.
IEEE Journal of Biomedical and Health Informatics|August 5, 2022
Synthetic Patient Data Generation and Evaluation in Disease Prediction Using Small and Imbalanced DatasetsAntonio J Rodriguez-Almeida, Himar Fabelo, Samuel Ortega, et al.
The Pediatric Infectious Disease Journal|May 1, 1992
Escherichia coli virulence factors and 99mTc-dimercaptosuccinic acid renal scan in children with febrile urinary tract infectionB A Jantausch, B L Wiedermann, S I Hull, et al.
Epidemiology and Infection|May 8, 2019
Extension of the known distribution of a novel clade C betacoronavirus in a wildlife hostI F Saldanha, B Lawson, H Goharriz, et al.
Annals of Epidemiology|March 20, 2012
Coronary death and myocardial infarction among Hispanics in the Northern Manhattan Study: exploring the Hispanic paradoxJoshua Z Willey, Carlos J Rodriguez, Yeseon Park Moon, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 21, 2007
Prophylactic treatment of haemophilia patients with inhibitors: clinical experience with recombinant factor VIIa in European Haemophilia CentresM Morfini, G Auerswald, R A Kobelt, et al.
Pageof 312